Bergan Kdv Wealth Management, LLC Vericel Corp Transaction History

Bergan Kdv Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$8.5 - $15.82 $143,650 - $267,358	-16,900 Closed	0 $0
Q1 2020 Apr 24, 2020	SELL	$7.25 - $19.22 $65,975 - $174,902	-9,100 Reduced 35.0%	16,900 $155,000
Q4 2019 Feb 10, 2020	SELL	$13.77 - $19.2 $192,780 - $268,800	-14,000 Reduced 35.0%	26,000 $452,000
Q1 2019 May 09, 2019	BUY	$16.23 - $20.29 $649,200 - $811,600	40,000 New	40,000 $700,000

290

49.5M

98.2K

135K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $1.93B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Bergan Kdv Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bergan Kdv Wealth Management, LLC with notifications on news.